Dr. Pierre is available for public speaking and Continuing Medical Education (CME) events on topics related to psychiatry and mental illness, psychotic disorders, cannabis and cannabis-induced psychosis, delusion-like beliefs and conspiracy theories, and suicide prevention.
Selected speaking events:
◉ “New frontiers in conspiracy theory: Conspiracy, ideology, and extremist violence”
American Academy of Psychiatry and the Law 55th Annual Meeting; Vancouver, Canada; October 27, 2024.
◉ “Gangstalking: Real-life harassment, paranoid psychosis, or social contagion?”
Harbor-UCLA Medical Center, Department of Psychiatry Grand Rounds; Torrance CA; June 4, 2024.
◉ “Conspiracy theory beliefs: A sane response to an insane world?”
University of Illinois at Chicago (UIC) College of Medicine, Department of Psychiatry Grand Rounds; Chicago, IL; May 22, 2024.
◉ “Conspiracy theories gone wild: Who believes them, why, and how we can help?”
American Psychiatric Association Annual Meeting; New York, NY; May 4, 2024.
◉ “Conspiracy theory beliefs: A sane response to an insane society?”
Workshop on Conspiratorial Thinking & Origins, Spread, and Consequences; California Institute of Technology, Pasadena, CA; September 14-15, 2023.
◉ “Are conspiratorial beliefs pathological?”
University of Birmingham, UK; April 24-25, 2023.
◉ “Conspiracy theories gone wild: Belief, ideology, and threat assessment”
Association of Threat Assessment Professionals Winter Conference; Orlando, FL; February 8, 2023
◉ “Uniting America to avoid, or if needed, win the next war” (panel discussion)
◉ “Why have false beliefs and conspiracy theories become so powerful?”
The Commonwealth Club of California; September 1, 2022
◉ “Conspiracy theories gone wild: Belief, ideology, and intervention”
International Forensic Psychiatry Lecture Series; McMaster University; June 2, 2022.
◉ “Synthetic cannabinoids: Smoking guns, moving targets”
Webinar on New Psychoactive Substances: Synthetic stimulants/synthetic cannabinoids; International Society of Substance Use Professionals; May 27, 2022.
◉ “Rabbit holes, red pills, and radicalization: Psychiatric aspects of extremism and conspiracy theorists”
American Psychiatric Association Annual Meeting; New Orleans, LA; May 25, 2022
◉ “Medical conspiracy theories”
DeVos Medical Ethics Colloquy; Grand Valley State University; March 21, 2022
◉ “Conspiracy theories”
Cambridge Disinformation Summit Webinar 1; University of Cambridge, Judge Business School; January 27, 2022
◉ “Conspiracy theories in clinical practice”
Maryland Psychological Association Annual Convention; November 3, 2021.
◉ “Is technology making you sick? A discussion on how tech is impacting our lives”
Ethics and Society Online Community Speaker Series, Community Memorial Healthcare System; October 14, 2021.
◉ “Civil rights movements and conspiracy theories”
Panel Discussion Member; Creative Disruption and Social Movements Programme, Big Innovation Centre; UK. September 16, 2021.
◉ “Conspiracy theories: Mistrust, misinformation, and mitigation”
Grand Rounds, Department of Psychiatry and Biobehavioral Science, David Geffen School of Medicine at UCLA; February 25, 2020.
◉ “Suicide: Conceptual issues, risk assessment, and prevention”
Valley Hospital Medical Center Medical Conference, Rancho Palos Verdes, CA; July 30, 2021.
◉ “Conspiracy theories during COVID-19: Mistrust and misinformation”
7th Mandate—Commission for Citizenship, Governance, Institutional and External Affairs (CIVEX); February 16, 2021.
◉ “COVID and conspiracy theories”
UK Science Festivals Network Conference (online lecture); January 19, 2021.
◉ “Exploring scientific authority: From skepticism to conspiracy theory”
Science Events Summit, San Diego, CA; May 28, 2019.
◉ “Reefer madness 2020: Cannabinoids, synthetic cannabinoids, and psychosis”
California Association of Toxicologists Meeting Fall 2019; Oxnard, CA; November 4, 2019.
◉ “Marijuana in mental health”
Clinical Updates in Psychopharmacology, 31st Annual Premier Conference of the California Psychiatric Association, Dana Point, CA; September 21, 2018.
◉ “Real-world challenges in managing ‘dual diagnosis’ patients”
MDedge: News and Insights for Busy Physicians; September 5-12, 2018.
◉ “Cannabis for psychiatrists: Marijuana in mental health”
Psychopharmacology Update 29, Southern California Psychiatric Society, Los Angeles, CA; January 27, 2018.
◉ “Cannabis and psychosis: Potent risk, potential therapy”
UCLA Cannabis Research Symposium, Los Angeles, CA; April 20, 2017.
◉ “Underrepresented minority recruitment: Rationale, challenges, and strategies”
Workshop Chair; 43rd Annual Meeting of the American Association of Directors of Psychiatric Residency Training, Tucson, AZ; March 14, 2014.
◉ “Managing the side effects of antipsychotic medications”
111th Annual Florida Osteopathic Medical Association Convention, Westin, FL; February 20, 2014.
◉ “The pragmatic context of psychiatric diagnosis”
Symposium S19: Philosophical and Pragmatic Problems for DSM-5; 165th Annual Meeting American Psychiatric Association, Philadelphia, PA; May 5, 2012.